ANB Bank
IONS icon

ANB Bank’s Ionis Pharmaceuticals IONS Stock Holding History

ANB Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,733
Closed -$296K – 130
2026
Q2 		$296K Sell
3,733
-36
-1% -$2.71K 0.11% 114
2026
Q1 		$283K Buy
3,769
+576
+18% +$45.5K 0.11% 105
2025
Q4 		$253K Sell
3,193
-38
-1% -$2.86K 0.1% 110
2025
Q3 		$211K Buy
+3,231
New +$158K 0.09% 122

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

ANB Bank's IONS Position: Q3 2026 in Review

ANB Bank sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 3,733 shares — an estimated $296K sold.

ANB Bank first reported a position in IONS in Q3 2025 and held it in 4 quarters. The position peaked at $296K in Q2 2026. 194 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • ANB Bank reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • ANB Bank sold 3,733 Ionis Pharmaceuticals shares in Q3 2026, an estimated $296K.
  • ANB Bank first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • ANB Bank's Ionis Pharmaceuticals position peaked at $296K in Q2 2026.
  • 194 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on ANB Bank's 13F filing for Q3 2026, filed 9 Oct 2026.